Nobili S - Search Results

1

An overview of the clinical use of cabozantinib in the treatment of advanced non-clear-cell renal cell carcinoma (NCCRCC).

D'Angelo A, Bagby S, Di Pierro G, Chirra M, Nobili S, Mini E, Villari D, Roviello G. D'Angelo A, et al. Among authors: nobili s. Crit Rev Oncol Hematol. 2020 May;149:102921. doi: 10.1016/j.critrevonc.2020.102921. Epub 2020 Mar 3. Crit Rev Oncol Hematol. 2020. PMID: 32172222 Review.

2

Methicillin-resistant staphylococci in clean surgery. Is there a role for prophylaxis?

Mini E, Nobili S, Periti P. Mini E, et al. Among authors: nobili s. Drugs. 1997;54 Suppl 6:39-52. doi: 10.2165/00003495-199700546-00008. Drugs. 1997. PMID: 9474480 Review.

3

Does surgical prophylaxis with teicoplanin constitute a therapeutic advance?

Mini E, Nobili S, Periti P. Mini E, et al. Among authors: nobili s. J Chemother. 2000 Nov;12 Suppl 5:40-55. doi: 10.1080/1120009x.2000.11782317. J Chemother. 2000. PMID: 11131963 Review.

4

Oxaliplatin and protracted continuous 5-fluorouracil infusion in patients with pretreated advanced colorectal carcinoma.

Martoni A, Mini E, Pinto C, Nobili S, Gentile AL, Dentico P, Angelelli B, Scicolone S, Piana E, Mazzei T. Martoni A, et al. Among authors: nobili s. Ann Oncol. 2001 Apr;12(4):519-24. doi: 10.1023/a:1011103213297. Ann Oncol. 2001. PMID: 11398887 Free article. Clinical Trial.

5

Treatment of locally advanced hepatocellular carcinoma by hepatic intra-artery chemotherapy: a pilot study.

Mazzanti R, Giallombardo AL, Mini E, Nobili S, Neri B, Arena U, Pantaleo P, Fabbroni V, Ghilardi M, Gattai R, Bandettini L. Mazzanti R, et al. Among authors: nobili s. Dig Liver Dis. 2004 Apr;36(4):278-85. doi: 10.1016/j.dld.2003.12.013. Dig Liver Dis. 2004. PMID: 15115341 Clinical Trial.

6

Relationships between promoter polymorphisms in the thymidylate synthase gene and mRNA levels in colorectal cancers.

Morganti M, Ciantelli M, Giglioni B, Putignano AL, Nobili S, Papi L, Landini I, Napoli C, Valanzano R, Cianchi F, Boddi V, Tonelli F, Cortesini C, Mazzei T, Genuardi M, Mini E. Morganti M, et al. Among authors: nobili s. Eur J Cancer. 2005 Sep;41(14):2176-83. doi: 10.1016/j.ejca.2005.06.016. Eur J Cancer. 2005. PMID: 16182121

7

Cellular pharmacology of gemcitabine.

Mini E, Nobili S, Caciagli B, Landini I, Mazzei T. Mini E, et al. Among authors: nobili s. Ann Oncol. 2006 May;17 Suppl 5:v7-12. doi: 10.1093/annonc/mdj941. Ann Oncol. 2006. PMID: 16807468 Free article. Review.

8

Pharmacological strategies for overcoming multidrug resistance.

Nobili S, Landini I, Giglioni B, Mini E. Nobili S, et al. Curr Drug Targets. 2006 Jul;7(7):861-79. doi: 10.2174/138945006777709593. Curr Drug Targets. 2006. PMID: 16842217 Review.

9

Molecular characterization of established human colon carcinoma cell lines (HCT-8) made resistant to 5-fluorouracil by different selection schedules.

Tempestini A, Caciagli B, Morganti M, Witort E, Nobili S, Papucci L, Schiavone N, Donnini M, Landini I, Lapucci A, Perna F, Lulli M, Mazzei T, Sobrero A, Mini E, Capaccioli S. Tempestini A, et al. Among authors: nobili s. Oncol Res. 2005;16(3):143-56. doi: 10.3727/000000006783981189. Oncol Res. 2005. PMID: 16925115

10

Analysis of gene expression profiles reveals novel correlations with the clinical course of colorectal cancer.

Cavalieri D, Dolara P, Mini E, Luceri C, Castagnini C, Toti S, Maciag K, De Filippo C, Nobili S, Morganti M, Napoli C, Tonini G, Baccini M, Biggeri A, Tonelli F, Valanzano R, Orlando C, Gelmini S, Cianchi F, Messerini L, Luzzatto L. Cavalieri D, et al. Among authors: nobili s. Oncol Res. 2007;16(11):535-48. doi: 10.3727/096504007783438376. Oncol Res. 2007. PMID: 18306933

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

104 results

Search Page

Filters